Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows

v3.8.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
 9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Cash flows from operating activities    
Net income (loss) $ 283 $ (815)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:    
Depreciation and amortization expense 252 106
Share-based compensation expense 64 85
Non-cash interest expense 54 60
Amortization of debt issuance costs, deferred commitment fees, premium and discount 53 45
Loss on early extinguishment of debt 100 83
Total losses on derivatives, net 108 269
Net cash used for settlement of derivative instruments (59) (34)
Impairment Expense And Loss On Disposal Of Assets 15 10
Other (2) 10
Changes in operating assets and liabilities:    
Accounts and other receivables (33) (128)
Accounts receivable—related party (1) 0
Inventory 35 (28)
Accounts payable and accrued liabilities 20 34
Deferred revenue 58 (3)
Other, net (52) (13)
Net cash provided by (used in) operating activities 895 (319)
Cash flows from investing activities    
Property, plant and equipment, net (2,903) (3,449)
Investment in equity method investment (41) 0
Other 18 (50)
Net cash used in investing activities (2,926) (3,499)
Cash flows from financing activities    
Proceeds from issuances of debt 6,537 8,308
Repayments of debt (3,609) (4,181)
Debt issuance and deferred financing costs (85) (117)
Distributions and dividends to non-controlling interest (60) (60)
Payments related to tax withholdings for share-based compensation (4) (19)
Net cash provided by financing activities 2,779 3,931
Net increase in cash, cash equivalents and restricted cash 748 113
Cash, cash equivalents and restricted cash—beginning of period 1,827 1,736
Cash, cash equivalents and restricted cash—end of period $ 2,575 $ 1,849